Search details
1.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38060001
2.
Left ventricular assist device in cardiac amyloidosis: friend or foe?
Heart Fail Rev
; 28(2): 359-365, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36451061
3.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Article
in English
| MEDLINE | ID: mdl-33889952
4.
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia.
Br J Haematol
; 198(5): 916-922, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35701886
5.
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.
Blood
; 136(2): 171-182, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32266380
6.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Article
in English
| MEDLINE | ID: mdl-31869407
7.
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study.
Br J Haematol
; 193(2): 386-396, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33618438
8.
The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature.
Heart Fail Rev
; 26(6): 1371-1381, 2021 11.
Article
in English
| MEDLINE | ID: mdl-32219615
9.
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Blood
; 134(20): 1708-1711, 2019 11 14.
Article
in English
| MEDLINE | ID: mdl-31570488
10.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31816122
11.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant
; 24(9): 1814-1822, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29857196
12.
Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
Ann Hematol
; 96(9): 1421-1434, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28275823
13.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36111658
14.
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Ann Hematol
; 95(6): 863-70, 2016 May.
Article
in English
| MEDLINE | ID: mdl-27001309
15.
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Blood Adv
; 8(6): 1529-1540, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38231017
16.
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.
Am J Hematol
; 93(12): E386-E389, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30184246
17.
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments.
J Mark Access Health Policy
; 11(1): 2230663, 2023.
Article
in English
| MEDLINE | ID: mdl-37405228
18.
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
Int J Cardiol
; 371: 266-272, 2023 Jan 15.
Article
in English
| MEDLINE | ID: mdl-36067924
19.
Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort.
Hematology
; 28(1): 2253069, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37680028
20.
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
Mediterr J Hematol Infect Dis
; 15(1): e2023019, 2023.
Article
in English
| MEDLINE | ID: mdl-36908864